Understanding breast and cervical cancer stigma in Rwanda
Part of Cancer, Skin, Women’s health & pregnancy clinical trials.
This study uses interviews and surveys to learn about stigma related to breast and cervical cancer in Rwanda. It aims to help improve care and support for patients, caregivers, and healthcare workers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You can understand and speak English or Kinyarwanda
- You are able to give your consent to participate
- You are not a prisoner
- You are not pregnant
- Depending on the group: you are a breast or cervical cancer patient receiving treatment, a caregiver of such a patient, or a healthcare worker in Rwanda
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to bring breast ultrasound directly to district hospitals in Rwanda, so more women can be screened for breast cancer close to home — without having to travel long distances. It will test a new way of delivering ultrasound that is easier for patients and staff.
This study evaluates how to improve testing of hormone receptors (which helps guide breast cancer treatment) in Tanzania. It uses interviews or focus groups with breast cancer survivors, advocates, and healthcare workers, plus reviews of existing medical records.
This study aims to find practical ways to shorten the time between a cervical cancer diagnosis and starting treatment, using Botswana’s local testing system. If you are eligible, the study may help improve how quickly and smoothly patients get care after diagnosis.
This study tests a patient “navigator” approach to improve cervical cancer screening and prevention access in Senegal. You may be invited to help through community education, health facility work, or by being part of a screening-support household.
This study tests giving the HPV vaccine along with HPV screening to quickly reduce HPV infection and cervical cancer. It is for women aged 23-29 in Rwanda who choose to join.
This study tests tools to help people talk with employers and medical staff about breast cancer treatment while working. It aims to improve how treatment and job needs are discussed so patients can get support.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.